To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

Completed · Phase 3

Conditions studied: Seizure Disorder, Partial

In brief

To evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.

Key facts

Study ID

NCT00141388

Run by

Pfizer

People needed

455

Starts

1998-07-01

Expected to finish

2005-10-01

Last updated by the study team

2009-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must have met the inclusion criteria for the preceding double-blind study
• Have received double-blind study medication and wish to receive open-label pregabalin.

You may not qualify if…

• Cannot have absence seizures.

Where it is running

• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Tucson, Arizona, United States
• Pfizer Investigational Site — Tucson, Arizona, United States
• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Pasadena, California, United States
• Pfizer Investigational Site — Gainesville, Florida, United States
• Pfizer Investigational Site — Gainesville, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Plantation, Florida, United States
• Pfizer Investigational Site — Spring Hill, Florida, United States
• Pfizer Investigational Site — Tallahassee, Florida, United States
• Pfizer Investigational Site — Chicago, Illinois, United States
• Pfizer Investigational Site — Springfield, Illinois, United States
• Pfizer Investigational Site — Springfield, Illinois, United States
• Pfizer Investigational Site — Indianapolis, Indiana, United States
• Pfizer Investigational Site — Indianapolis, Indiana, United States
• Pfizer Investigational Site — Iowa City, Iowa, United States
• Pfizer Investigational Site — Kansas City, Kansas, United States
• Pfizer Investigational Site — Kansas City, Kansas, United States
• Pfizer Investigational Site — Louisville, Kentucky, United States
• Pfizer Investigational Site — Baltimore, Maryland, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.